We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Ranbaxy Eyes Merck’s Generics Unit

Law360 (January 10, 2007, 12:00 AM EST) -- India’s Ranbaxy Laboratories Ltd. may become the latest big generic maker to jump on the buyout bandwagon, with the company revealing on Tuesday that it is interested in bidding for the...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.